Evidence map›Paper›PMID 29186431›Full record

ArticleThe international journal of neuropsychopharmacology2018

Monoamine Oxidase A Gene Methylation and Its Role in Posttraumatic Stress Disorder: First Evidence from the South Eastern Europe (SEE)-PTSD Study.

Christiane Ziegler, Christiane Wolf, Miriam A Schiele, Elma Feric Bojic, Sabina Kucukalic, Emina Sabic Dzananovic, Aferdita Goci Uka, Blerina Hoxha, Valdete Haxhibeqiri, Shpend Haxhibeqiri and 21 more

Open access · goldAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Observational
  12. Article
  13. Article
  14. The role of BDNF methylation and ValHuman brain mapping · 2020
    Article
  15. Review
  16. Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy.Journal of neural transmission (Vienna, Austria : 1996) · 2018
    Review
  17. Epigenetic signature of MAOA and MAOB genes in mental disorders.Journal of neural transmission (Vienna, Austria : 1996) · 2018
    Review
  18. Plasticity of Functional MAOA Gene Methylation in Acrophobia.The international journal of neuropsychopharmacology · 2018
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 9 institutions in 4 countries.

Christiane ZieglerDepartment of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
Christiane WolfDepartment of Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Würzburg, Germany.
Miriam A SchieleDepartment of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
Elma Feric BojicDepartment of Genetics and Bioengineering, International Burch University, Sarajevo, Bosnia and Herzegovina.
Sabina KucukalicDepartment of Psychiatry, University Clinical Center, Sarajevo, Bosnia and Herzegovina.
Emina Sabic DzananovicDepartment of Psychiatry, University Clinical Center, Sarajevo, Bosnia and Herzegovina.
Aferdita Goci UkaDepartment of Psychiatry, University Clinical Center of Kosovo, Prishtina, Kosovo.
Blerina HoxhaDepartment of Psychiatry, University Clinical Center of Kosovo, Prishtina, Kosovo.
Valdete HaxhibeqiriDepartment of Medical Biochemistry, University Clinical Center of Kosovo, Prishtina, Kosovo.
Shpend Haxhibeqiri
Nermina KravicDepartment of Psychiatry, University Clinical Center of Tuzla, Tuzla, Bosnia and Herzegovina.
Mirnesa Muminovic UmihanicCommunity Health Center, Zivinice, Bosnia and Herzegovina.
Ana Cima FrancDepartment of Psychiatry, University Hospital Center Zagreb, Zagreb, Croatia.
Nenad JaksicDepartment of Psychiatry, University Hospital Center Zagreb, Zagreb, Croatia.
Romana BabicDepartment of Psychiatry, University Clinical Center of Mostar, Mostar, Bosnia and Herzegovina.
Marko PavlovicDepartment of Psychiatry, University Clinical Center of Mostar, Mostar, Bosnia and Herzegovina.
Bodo WarringsDepartment of Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Würzburg, Germany.
Alma Bravo MehmedbasicDepartment of Psychiatry, University Clinical Center, Sarajevo, Bosnia and Herzegovina.
Dusko RudanDepartment of Psychiatry, University Hospital Center Zagreb, Zagreb, Croatia.
Branka Aukst-MargeticDepartment of Psychiatry, University Hospital Sestre Milosrdnice, Zagreb, Croatia.
Abdulah KucukalicDepartment of Psychiatry, University Clinical Center, Sarajevo, Bosnia and Herzegovina.
Damir MarjanovicDepartment of Genetics and Bioengineering, International Burch University, Sarajevo, Bosnia and Herzegovina.
Dragan BabicDepartment of Psychiatry, University Clinical Center of Mostar, Mostar, Bosnia and Herzegovina.
Nada BozinaDepartment of Laboratory Diagnostics, University Hospital Center Zagreb, Zagreb, Croatia.
Miro JakovljevicDepartment of Psychiatry, University Hospital Center Zagreb, Zagreb, Croatia.
Osman SinanovicDepartment of Neurology, University Clinical Center of Tuzla, Tuzla, Bosnia and Herzegovina.
Esmina AvdibegovicDepartment of Psychiatry, University Clinical Center of Tuzla, Tuzla, Bosnia and Herzegovina.
Ferid AganiFaculty of Medicine, University Hasan Prishtina, Prishtina, Kosovo.
Alma Dzubur-KulenovicDepartment of Psychiatry, University Clinical Center, Sarajevo, Bosnia and Herzegovina.
Jürgen DeckertDepartment of Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Würzburg, Germany.
Katharina DomschkeDepartment of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
University Hospital Centre Zagreb · HRUniversity of Sarajevo · BAUniversity Clinical Center of Kosovo · XKUniversity Clinical Center Tuzla · BAUniversity of Freiburg · DEUniversity of Würzburg · DEInternational Burch University · BASisters of Charity Hospital · HRUniversity of Prishtina · XK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Posttraumatic stress disorder is characterized by an overactive noradrenergic system conferring core posttraumatic stress disorder symptoms such as hyperarousal and reexperiencing. Monoamine oxidase A is one of the key enzymes mediating the turnover of noradrenaline. Here, DNA methylation of the monoamine oxidase A gene exonI/intronI region was investigated for the first time regarding its role in posttraumatic stress disorder risk and severity. Methods: Monoamine oxidase A methylation was analyzed via direct sequencing of sodium bisulfite-treated DNA extracted from blood cells in a total sample of N=652 (441 male) patients with current posttraumatic stress disorder, patients with remitted posttraumatic stress disorder, and healthy probands (comparison group) recruited at 5 centers in Bosnia-Herzegovina, Croatia, and the Republic of Kosovo. Posttraumatic stress disorder severity was measured by means of the Clinician-Administered Posttraumatic Stress Disorder Scale and its respective subscores representing distinct symptom clusters. Results: In the male, but not the female sample, patients with current posttraumatic stress disorder displayed hypermethylation of 3 CpGs (CpG3=43656362; CpG12=43656514; CpG13=43656553, GRCh38.p2 Assembly) as compared with remitted Posttraumatic Stress Disorder patients and healthy probands. Symptom severity (Clinician-Administered Posttraumatic Stress Disorder Scale scores) in male patients with current posttraumatic stress disorder significantly correlated with monoamine oxidase A methylation. This applied particularly to symptom clusters related to reexperiencing of trauma (cluster B) and hyperarousal (cluster D). Conclusions: The present findings suggest monoamine oxidase A gene hypermethylation, potentially resulting in enhanced noradrenergic signalling, as a disease status and severity marker of current posttraumatic stress disorder in males. If replicated, monoamine oxidase A hypermethylation might serve as a surrogate marker of a hyperadrenergic subtype of posttraumatic stress disorder guiding personalized treatment decisions on the use of antiadrenergic agents.

Indexed as

AdultBosnia and HerzegovinaCroatiaDNA MethylationEpigenesis, GeneticFemaleHumansKosovoMaleMiddle AgedMonoamine OxidaseSeverity of Illness IndexSex FactorsStress Disorders, Post-TraumaticMonoamine Oxidase

Identifiers

PMID29186431
PMCPMC5932467
OpenAlexW2770499238

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.